"Stop Sepsis Act"; requires hospitals to establish sepsis recognition and treatment protocols, train staff, and establish quality measures.*
A1950, the “Stop Sepsis Act,” requires every general and special hospital licensed in New Jersey to adopt, implement, and periodically update evidence-based protocols for the early recognition and treatment of sepsis, severe sepsis, and septic shock. The protocols must address adult, geriatric, obstetric, and pediatric patients, and must include screening and early recognition procedures, criteria for identifying which patients should be treated under the protocols or excluded from them, treatment guidelines, infection-source identification, and time goals for early antibiotic administration. Hospitals must also train clinical staff involved in sepsis recognition, treatment, or prevention and update that training when protocols change.
The bill also shifts the focus from state pre-approval of hospital protocols to internal hospital quality improvement and public reporting. Hospitals must collect quality measures tied to adherence to their own sepsis protocols, and the Commissioner of Health must develop and publish an annual online report card with risk-adjusted sepsis-related measures, including mortality, length of stay, present-on-admission cases, and hospice discharges. In addition, the bill bars Medicaid managed care organizations and other health benefits plans from overriding a treating provider’s clinical judgment on sepsis diagnosis and treatment through denial, downcoding, retrospective review, or payment reductions based on alternative definitions or proprietary algorithms when the diagnosis is coded under ICD-10-CM guidelines.
The bill amends existing hospital infection-reporting law to reinforce that infection-rate data must be risk adjusted and publicly displayed in a clinically valid, transparent format. It also directs the Department of Health to adopt implementing regulations and delays the effective date until the twelfth month after those regulations are adopted. In practical terms, the bill would expand hospital compliance obligations, create a new public-facing sepsis quality reporting framework, and limit payer practices that could interfere with sepsis care decisions.
The general sentiment reflected in the available record is strongly favorable. The Assembly Health Committee reported the bill with amendments on May 11, 2026, by an 8-0 vote, indicating unanimous committee support. No opposition or negative testimony is included in the provided materials, and the bill’s structure suggests a patient-safety and quality-improvement purpose that likely drove the positive reception.
The main point of contention apparent from the text is not whether sepsis should be addressed, but how much authority should rest with hospitals, the Department of Health, and insurers. The bill removes earlier language that would have required hospitals to submit protocols for departmental review and instead emphasizes hospital-led implementation and quality measurement. It also explicitly restricts insurers and managed care organizations from using proprietary review methods to second-guess sepsis diagnoses, which may be viewed as protecting clinicians and patients but could raise concerns among payers about utilization review and claims management.
The bill would amend P.L.2007, c.196 and supplement Title 26 to impose new hospital obligations for sepsis protocols, staff training, internal quality measurement, and public reporting. It would require the Department of Health to create and maintain an annual sepsis report card using risk-adjusted hospital data, and it would limit certain insurer and Medicaid managed care review practices related to sepsis diagnosis and payment. Hospitals, the Department of Health, and health plans would all be affected, with hospitals bearing the primary compliance burden.
The available legislative history shows clear support for the bill. The Assembly Health Committee reported it with amendments on a unanimous 8-0 vote, and there are no recorded dissenting remarks or opposing votes in the provided materials. The bill appears to have been received as a patient-safety measure aimed at improving early sepsis detection, treatment consistency, and transparency in hospital performance.
The most notable policy tension is between clinical autonomy and oversight. Hospitals are required to adopt evidence-based sepsis protocols and train staff, but the bill removes the earlier requirement that protocols be submitted to the Department of Health for approval, suggesting some sensitivity to administrative burden and hospital flexibility. Another potential area of contention is the payer restriction: the bill prohibits managed care organizations and health plans from substituting their own clinical judgment or using retrospective review tools to deny or reduce payment for documented sepsis cases, which protects providers but may be viewed by insurers as limiting fraud control, medical necessity review, and claims management.